Clinical Trials in Houston

Showing 3621-3640 of 15,366 trials

A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4

NCT07052682

The main aim of this study is to evaluate the safety and tolerability of ontamalimab in participants with a liver disease called nonalcoholic steatohepatitis (NASH) or metabolic dysfunction-associated steatohepatitis (MASH) with scarring in the liver (fibrosis stage 1 to 4). The study will also check if there are any important changes in the body's health markers (biomarkers) from the beginning of the study to see if ontamalimab stops liver scarring and reduces inflammation of the liver. Participants will be in the study for approximately up to 46 weeks.

Steatohepatitis

Takeda11 participantsStarted Jan 2023

Chandler, Arizona, United States • Tucson, Arizona, United States • Coronado, California, United States +12 more locations

Active Not Recruiting< 1 mile

Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)

NCT03459456

The investigators propose to synchronize automated measurements of behavior - head, body, and face dynamics, gaze, and vocal prosody - with simultaneous recordings of brain activity in clinically relevant contexts.

OCDObsessive-Compulsive Disorder

Baylor College of Medicine27 participantsStarted Jun 2018

Pittsburgh, Pennsylvania, United States • Providence, Rhode Island, United States • Houston, Texas, United States

A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4

Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)

Find Trials by Condition in Houston

Superior Hypogastric Nerve Plexus Block With Bupivacaine After Robotic Resection of Endometriosis

Bone Loss in Melanoma Survivors Receiving Immunotherapy

A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

A Study of ADRX-0706 in Select Advanced Solid Tumors

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

Prospective Evaluation Of Outcomes For Patients Undergoing Radiofrequency Ablation (RFA) Using HALO Ultra Device For Gastric Antral Vascular Ectasia (GAVE)

Home-Based Exercise to Treat Decreased Physical Function in Patients With Varying Levels of Kidney Function

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008)

Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906

Actis Total Hip System 2 Year Follow-up

A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer

Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation